MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-SR and XL 180mg capsules (Napp Pharmaceuticals Ltd), Angitil SR 180 capsules (Ethypharm UK Ltd), Viazem XL 180mg capsules (Thornton & Ross Ltd) and Zemtard 180 XL capsules (Galen Ltd).

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Adizem-SR 90mg capsules (Napp Pharmaceuticals Ltd) and Angitil SR 90 capsules (Ethypharm UK Ltd).

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-XL 240mg capsules (Napp Pharmaceuticals Ltd), Angitil XL 240 capsules (Ethypharm UK Ltd), Viazem XL 240mg capsules (Thornton & Ross Ltd) and Zemtard 240 XL capsules (Galen Ltd).

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-XL 300mg capsules (Napp Pharmaceuticals Ltd), Angitil XL 300 capsules (Ethypharm UK Ltd), Tildiem LA 300, Viazem XL 300mg capsules (Thornton & Ross Ltd) and Zemtard 300 XL capsules (Galen Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Eliquis 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Eliquis 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.